Back to Search Start Over

Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury

Authors :
Divella, C.
Stasi, A.
Franzin, R.
Rossini, M.
Pontrelli, P.
Sallustio, F.
Netti, G. S.
Ranieri, E.
Lacitignola, L.
Staffieri, F.
Crovace, A. M.
Lucarelli, G.
Ditonno, P.
Battaglia, M.
Daha, M. R.
van der Pol, P.
van Kooten, C.
Grandaliano, Giuseppe
Gesualdo, L.
Stallone, G.
Castellano, G.
Grandaliano G. (ORCID:0000-0003-1213-2177)
Divella, C.
Stasi, A.
Franzin, R.
Rossini, M.
Pontrelli, P.
Sallustio, F.
Netti, G. S.
Ranieri, E.
Lacitignola, L.
Staffieri, F.
Crovace, A. M.
Lucarelli, G.
Ditonno, P.
Battaglia, M.
Daha, M. R.
van der Pol, P.
van Kooten, C.
Grandaliano, Giuseppe
Gesualdo, L.
Stallone, G.
Castellano, G.
Grandaliano G. (ORCID:0000-0003-1213-2177)
Publication Year :
2021

Abstract

Pentraxins are a family of evolutionarily conserved pattern recognition molecules with pivotal roles in innate immunity and inflammation, such as opsonization of pathogens during bacterial and viral infections. In particular, the long Pentraxin 3 (PTX3) has been shown to regulate several aspects of vascular and tissue inflammation during solid organ transplantation. Our study investigated the role of PTX3 as possible modulator of Complement activation in a swine model of renal ischemia/reperfusion (I/R) injury. We demonstrated that I/R injury induced early PTX3 deposits at peritubular and glomerular capillary levels. Confocal laser scanning microscopy revealed PTX3 deposits co-localizing with CD31+ endothelial cells. In addition, PTX3 was associated with infiltrating macrophages (CD163), dendritic cells (SWC3a) and myofibroblasts (FSP1). In particular, we demonstrated a significant PTX3-mediated activation of classical (C1q-mediated) and lectin (MBL-mediated) pathways of Complement. Interestingly, PTX3 deposits co-localized with activation of the terminal Complement complex (C5b-9) on endothelial cells, indicating that PTX3-mediated Complement activation occurred mainly at the renal vascular level. In conclusion, these data indicate that PTX3 might be a potential therapeutic target to prevent Complement-induced I/R injury.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1256811000
Document Type :
Electronic Resource